• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Biol . Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion

tetano

Editor, Senior Moderator
PLoS Biol


. 2025 Jan 21;23(1):e3002982.
doi: 10.1371/journal.pbio.3002982. Online ahead of print. Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion

Harriet V Mears[SUP] 1 [/SUP], George R Young[SUP] 1 2 [/SUP], Theo Sanderson[SUP] 3 [/SUP], Ruth Harvey[SUP] 4 [/SUP], Jamie Barrett-Rodger[SUP] 1 5 [/SUP], Rebecca Penn[SUP] 1 [/SUP], Vanessa Cowton[SUP] 6 [/SUP], Wilhelm Furnon[SUP] 6 [/SUP], Giuditta De Lorenzo[SUP] 6 [/SUP], Marg Crawford[SUP] 7 [/SUP], Daniel M Snell[SUP] 7 [/SUP], Ashley S Fowler[SUP] 7 [/SUP], Anob M Chakrabarti[SUP] 1 8 [/SUP], Saira Hussain[SUP] 1 [/SUP], Ciarán Gilbride[SUP] 1 [/SUP], Edward Emmott[SUP] 9 [/SUP], Katja Finsterbusch[SUP] 10 [/SUP], Jakub Luptak[SUP] 11 [/SUP], Thomas P Peacock[SUP] 12 [/SUP], Jérôme Nicod[SUP] 7 [/SUP], Arvind H Patel[SUP] 6 13 [/SUP], Massimo Palmarini[SUP] 6 13 [/SUP], Emma Wall[SUP] 14 15 [/SUP], Bryan Williams[SUP] 15 [/SUP], Sonia Gandhi[SUP] 16 [/SUP], Charles Swanton[SUP] 5 [/SUP], David L V Bauer[SUP] 1 13 [/SUP]



Affiliations
Free article Abstract

Coronaviruses express their structural and accessory genes via a set of subgenomic RNAs, whose synthesis is directed by transcription regulatory sequences (TRSs) in the 5' genomic leader and upstream of each body open reading frame. In SARS-CoV-2, the TRS has the consensus AAACGAAC; upon searching for emergence of this motif in the global SARS-CoV-2 sequences, we find that it evolves frequently, especially in the 3' end of the genome. We show well-supported examples upstream of the Spike gene-within the nsp16 coding region of ORF1b-which is expressed during human infection, and upstream of the canonical Envelope gene TRS, both of which have evolved convergently in multiple lineages. The most frequent neo-TRS is within the coding region of the Nucleocapsid gene, and is present in virtually all viruses from the B.1.1 lineage, including the variants of concern Alpha, Gamma, Omicron and descendants thereof. Here, we demonstrate that this TRS leads to the expression of a novel subgenomic mRNA encoding a truncated C-terminal portion of Nucleocapsid, which is an antagonist of type I interferon production and contributes to viral fitness during infection. We observe distinct phenotypes when the Nucleocapsid coding sequence is mutated compared to when the TRS alone is ablated. Our findings demonstrate that SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level.


 
Back
Top Bottom